Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter H Moos

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The Journal of Organic Chemistry|January 8, 2003
Efficient syntheses of benzothiazepines as antagonists for the mitochondrial sodium-calcium exchanger: potential therapeutics for type II diabetesYazhong Pei, Michael J Lilly, David J Owen, et al.
Biochemical Pharmacology|October 21, 2021
Pathogenic mitochondrial dysfunction and metabolic abnormalitiesWalter H Moos, Douglas V Faller, Ioannis P Glavas, et al.
Biochemical Pharmacology|July 14, 2022
Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injuryWalter H Moos, Douglas V Faller, Ioannis P Glavas, et al.
Plos One|April 12, 2013
A systematic screen of FDA-approved drugs for inhibitors of biological threat agentsPeter B Madrid, Sidharth Chopra, Ian D Manger, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The Journal of Organic Chemistry|January 8, 2003
Efficient syntheses of benzothiazepines as antagonists for the mitochondrial sodium-calcium exchanger: potential therapeutics for type II diabetesYazhong Pei, Michael J Lilly, David J Owen, et al.
Biochemical Pharmacology|October 21, 2021
Pathogenic mitochondrial dysfunction and metabolic abnormalitiesWalter H Moos, Douglas V Faller, Ioannis P Glavas, et al.
Biochemical Pharmacology|July 14, 2022
Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injuryWalter H Moos, Douglas V Faller, Ioannis P Glavas, et al.
Plos One|April 12, 2013
A systematic screen of FDA-approved drugs for inhibitors of biological threat agentsPeter B Madrid, Sidharth Chopra, Ian D Manger, et al.
Pageof 3